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Gastrinsl adhesion by binding to E-cadherin at the cell membrane and, when translocated
into the nucleus, mediates signalling by activation of transcription factors such as TCF4. Mutations of the
components of the Wnt/β-catenin pathway are found in many gastrointestinal cancers. Gastrins, including
amidated (Gamide) and glycine-extended (Ggly) gastrin17, stimulate the proliferation of gastrointestinal
cancer cells. Gastrins also regulate β-catenin signalling through multiple pathways which seem to converge
on p21-activated kinase 1 (PAK1). In this study, we have investigated the role of PAK1 in the regulation
of β-catenin signalling by gastrins. Here we report for the ﬁrst time that PAK1 associated with β-catenin. Both
Gamide and Ggly stimulated the phosphorylation and activation of β-catenin in a PAK1-dependent manner. A
kinase-inactive mutant PAK1K299A blocked the gastrin-stimulated dissociation of β-catenin from E-cadherin,
translocation of β-catenin from the cell membrane to the nucleus, and association of β-catenin with the
transcription factor TCF4. The PAK1K299A mutant also inhibited the stimulation of the expression of c-myc and
cyclin D1, and of cell proliferation and migration, by gastrins. The results indicate that gastrins regulate
β-catenin signalling through a PAK1-dependent pathway. PAK1 seems to be the point of convergence of
multiple signalling pathways activated by gastrins.
© 2008 Elsevier B.V. All rights reserved.1. Introductionβ-catenin is a multifunctional protein which regulates both
cell–cell adhesion and nuclear transcription. Membrane-localized
β-catenin is mostly bound to E-cadherin at adherens junctions, which
aremembrane structures that maintain epithelial cell contact, polarity
and communication [1]. The loss of adherens junctions causes the
epithelial-to-mesenchymal transition, a change in cellular phenotype
associated with the progression of cancers of epithelial origin [2].
The down-regulation of E-cadherin and the loss of β-catenin and
E-cadherin from the cell membrane are key events in this process,
especially in breast and colon carcinomas [2–4]. β-catenin also
mediates nuclear signalling in the Wnt pathway, by binding to
transcription factors of the lymphoid enhancing factor-1 (LEF-1)/T-
cell factor (TCF) family in the nucleus [5–7]. Among the TCF family,
TCF4 has been recognized as a critical transcriptional switch for
downstream genes in Wnt signalling [8]. Activation of the β-catenin/
TCF4 transcriptional complex increases expression of genes, such as c-
myc and cyclin D1, which themselves further stimulate cell migration
and proliferation [9,10].
The relative importance of the twodivergent functions ofβ-catenin–
cell to cell adhesion and nuclear transcription – is controlled by13 9458 1650.
l rights reserved.phosphorylation. Cytoplasmic β-catenin forms a complex with casein
kinase-1 (CK-1), glycogen synthase kinase-3 (GSK-3), a scaffold protein
and axin. CK-1-dependent phosphorylation of β-catenin at Ser45
provides a recognition site for GSK-3, and allows it to phosphorylate
β-catenin at positions Thr41, Ser37, and Ser33 [11–13]. The phosphory-
lated β-catenin is targeted for ubiquitination and degradation. In
contrast β-catenin hypo-phosphorylated at these neighbouring resi-
dues translocates to the nucleus, where it interacts with transcription
factors of the LEF-1/TCF family.
The gastrins are a family of gastrointestinal peptide hormones,
which include both amidated (Gamide) and glycine-extended (Ggly)
forms. In addition to their well-deﬁned effects on gastric acid
secretion, both Gamide and Ggly have been implicated in a number
of other effects including stimulation of cell proliferation [14,15],
inhibition of apoptosis [16] and acceleration of neoplastic transforma-
tion [17–20]. Gamide acts via the cholecystokinin-2 receptor (CCK-
2R); in contrast the effects of Ggly are mediated by a distinct receptor,
which has not been isolated or cloned [20]. Interestingly the different
forms of gastrin are also active in different regions of the gastro-
intestinal tract. Thus Gamide has been implicated in the development
of gastric cancer in mouse models, while Ggly accelerates the early
stages in the progression to colorectal cancer [18–20].
Since mutations of the components in the Wnt pathway are found
in many gastrointestinal cancers [[21–23], the effects of gastrins on
β-catenin signalling have mainly been studied in gastrointestinal
cancer cells. Gamide stabilizes the β-catenin protein and activates the
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activation of c-myc and cyclin D1 [24–27], which in turn activate
proliferation of gastrointestinal cancer cells [24,26]. Gamide stimulates
β-catenin dissociation from the cell membrane and translocation to
the nucleus via Src-, mitogen activated protein kinase (MAPK)- and
phosphatidylinositol 3 kinase (PI3K)-dependent pathways [28].
Although the latter two signalling pathways are also involved in
Ggly-induced transfer of β-catenin from the cell membrane to the
cytoplasm [29], the effects of Ggly on β-catenin/TCF signalling are not
known. Recently Janus kinase 2 (JAK2) has been found to act upstream
of PI3K in the regulation of E-cadherin-dependent cell–cell adhesion
by Gamide [30]. Similarly Ggly also activates JAK2 and Src upstream of
PI3K [31]. Thus multiple signalling pathways seem to be involved in
the regulation of the cellular distribution and functions of β-catenin
by gastrins. Intriguingly the gastrin gene is itself up-regulated by a
β-catenin/TCF activated pathway in a mouse model of the hereditary
condition adenomatous polyposis coli (APC) [32].
p21-activated kinase 1 (PAK1) is a downstream effector of the Rho
GTPases Rac1 and Cdc42. PAK1 kinase activity has been implicated in
various cellular processes such as cytoskeletal reorganization, cell
growth, motility, morphogenesis, and gene regulation [33]. In addition
to its role in the cytoplasm, PAK1 also has awell-established role in theFig. 1. PAK1 associates with β-catenin and mediates its gastrin-induced translocation from
(10 nM) for the indicated times. (A) Cell lysates were immunoprecipitated with anti-PAK
immunoprecipitation; IB: immunoblotting. (B–E) Cells were stimulated with Gamide (10 nM
with mouse anti-β-catenin and rabbit anti-PAK1 antibodies as described in Materials and me
catenin, red) or Alexa Fluor 488-conjugated anti-rabbit antibodies (PAK1, green) the sample
merged image represent co-localization of PAK1 and β-catenin. In C to E, the nucleus is sta
localized in the nucleus. Cont: untreated control cells; PAK1K299A: a kinase-inactive mutant.
experiments after 24 h treatment. KD: kinase-inactive PAK1-transfected cells; siRNA: smallnucleus [33], where it associates with chromatin leading to modula-
tion of transcription [34]. PAK1 can also phosphorylate downstream
target proteins such as Snail and Integrin-linked kinase, causing them
to translocate into the nucleus [35,36]. In particular, PAK1 promotes
transcriptional repression by Snail, leading to decreased expression of
E-cadherin, which contributes to the process of epithelial-to-
mesenchymal transition [35]. PAK1 functions as a key node in various
signalling pathways leading to cell survival, migration and growth. For
instance, activated PAK1 stimulates MAPK, nuclear factor κB (NFκB),
and c-Jun N-terminal kinase (JNK) pathways to bring about expression
of genes important for cell survival, migration and carcinogenesis [33].
PAK1 itself can be phosphorylated and activated by PI3K/Akt [37].
JAK2 and Src act upstream of PI3K leading to the activation of PI3K
which in turn activates Akt [30,31]. Therefore PAK1 could function as a
downstream node for Src, JAK2, and PI3K/Akt pathways stimulated by
gastrins in the regulation of β-catenin signalling. PAK1 expression has
been reported to increase in the progression of colorectal carcinomas
to metastasis [38].
We have previously shown that gastrins stimulate PAK1 activity, and
that PAK1 is essential for the inhibition of apoptosis induced by either
Gamide or Ggly [39]. The aim of the presentwork was to investigate the
role of PAK1 in the regulation ofβ-catenin signalling and the stimulationcell membrane to nucleus. IMGE-5 cells were stimulated with Gamide (10 nM) or Ggly
1 antibody followed by Western blotting with anti-β-catenin or PAK1 antibody. IP:
) or Ggly (10 nM) for 1 h (B) or 24 h (C–E). At each time, cells were ﬁxed and incubated
thods. After incubationwith secondary Alexa Fluor 546-conjugated goat anti-mouse (β-
s were analyzed using a Nikon confocal microscope. The yellow or orange areas in the
ined blue, and the white areas in the merged image represent PAK1 and β-catenin co-
(F) The bar graph summarises the data (Mean±SEM) obtained in at least 3 independent
interfering RNA of PAK1 transfected cells; ⁎: Pb0.05.
Fig. 1 (continued).
1945H. He et al. / Biochimica et Biophysica Acta 1783 (2008) 1943–1954of cell proliferation by both Gamide and Ggly. Here we show that PAK1
mediates gastrin-induced phosphorylation of β-catenin, resulting in a
shift of β-catenin from the cell membrane to the nucleus, and a gastrin-
dependent activation of the β-catenin/TCF4 pathway.
2. Materials and methods
2.1. Cell culture, reagents and transfection
The IMGE-5 cell line was established from the gastric mucosa of mice transgenic for
a temperature-sensitive mutant of the SV40 large T antigen and has been shown to
proliferate in response to Gamide or Ggly [40]. IMGE-5 cells were generally grown at
33 °C inDulbecco'smodiﬁed Eagle'smedium (DMEM) containing 1 unit/mlγ-interferon,
5% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. All experiments have been
performed on cells between passages 20 and 30.
Amidated (Gamide) and glycine-extended (Ggly) gastrin17 were custom synthe-
sised by Auspep (Melbourne, Australia). PAKK299A was generously provided by Dr. G. M.
Bokoch (The Scripps Research Institute, La Jolla, CA). Rabbit anti-PAK and anti-actinantibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
antibodies against E-cadherin, β-catenin, phospho-β-catenin (Thr41/Ser45), TCF4, c-myc
andcyclinD1, anda SignalSilencePAK1small interferingRNAs (siRNA)kitwere purchased
from Cell Signalling Technology (Genesearch, Melbourne, Australia). Anti-non-phos-
phorylated β-catenin antibody (8E4) was purchased from Upstate Biotechnology (Lake
Placid, NY). Anti-β-catenin mouse antibody was from BD Transduction Laboratories (BD
Biosciences Pharmingen).
IMGE-5 cells were transfected with cDNA encoding PAKK229A using Lipofectin
Reagent (Invitrogen, Melbourne, Australia) according to the manufacturer's instruc-
tions. Stable clones were selected with G418 (800 μg/ml). Transfectionwith PAK1 siRNA
or control siRNA at a concentration of 100 nM was carried out in serum-free DMEM
with transfection reagent according to the manufacturer's instructions.
2.2. Immunoﬂuorescent staining
IMGE-5 cells were seeded on glass cover slips in a 24-well plate at 1×104 cells/
well, and incubated in DMEM containing 1 unit/ml γ-interferon, 5% FBS, 100 U/ml
penicillin, and 100 µg/ml streptomycin at 33 °C for 2 days. On the third day, the cells
were transferred into DMEM without γ-interferon and FBS. After 24 h serum
Fig. 1 (continued).
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39 °C for 1 h or 24 h.
At each time point, the cells were washed twice with PBS, ﬁxed with cold
methanol and permeabilized with 0.2% Triton-X 100 in PBS. The cells were then
blocked with 0.2% gelatin in PBS at room temperature for 30 min. After 2 washes in
PBS, the cells were incubated with anti-β-catenin and anti-PAK1 antibodies in PBS at
4 °C overnight. The cells were washed three times in PBS, and then incubated with
secondary Alexa Fluor 546-conjugated goat anti-mouse or Alexa Fluor 488-conjugated
anti-rabbit antibodies from Molecular Probes (Invitrogen, Melbourne, Australia) at
room temperature for 1 h. The cells were then washed three times and incubated in
300 nM DAPI (4′,-6-diamidino-2-phenylindole dihydrochloride, Molecular Probes) in
PBS for 5 min. The cells were thenwashed twice in PBS followed by two further washes
in water. Finally the cover slips with stained cells were mounted on a slide using
mounting gel from Beckman Coulter (Melbourne, Australia). The samples were
observed and analyzed using a confocal microscope (Nikon, Lidcombe, Australia).
Negative controls, in which the ﬁxed cells were incubated with the labelled secondary
antibodies without the primary antibodies, did not reveal any signiﬁcant cell-
associated ﬂuorescence. The resultant images were analyzed using Image J computer
software (http://rsb.info.nih.gov/ij/ (NIH, Bethesda, MD)). In each 24 h image, the cells
with nuclear staining for PAK1 and β-catenin were counted and the number expressed
as a percentage of the total number of cells (approximately 100) observed.
2.3. Immunoprecipitation and Western blot analysis
IMGE-5 cells were seeded in 10 cm diameter dishes, cultured to 50% conﬂuence at
33 °C, and serum-starved for 24 h. The cells were transferred to a 39 °C incubator andtreated with Gamide (10 nM) or Ggly (10 nM) for the time indicated in the text. The cells
were lysed in lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% NP40,
1 mM DTT, 5 μg/ml aprotinin, 5 μg/ml leupeptin and 1 mM PMSF). The cell lysates were
centrifuged at 12,000 rpm for 5 min at 4 °C. The resultant supernatants were
immunoprecipitated with protein A beads and anti-PAK1 or anti-TCF4 antibodies
followed by Western bolt with anti-β-catenin antibody; or immunoprecipitated with
protein A beads and anti-β-catenin antibody followed by Western blot with anti-E-
cadherin antibody.
2.4. Western blot analysis
Cell lysates from the different treatments indicated in the text were boiled in SDS
sample buffer and then electrophoresed on 10% SDS-polyacrylamide gels. After the
proteins had been transferred onto nitrocellulose membranes, the membranes were
blocked in 5% skim milk in TBST for 1 h at room temperature. Immunological blots were
then performed overnight at 4 °C in 5% milk or BSA/TBST buffer containing antibodies
speciﬁc for c-myc, cyclin D1, phosphorylated (phos-Thr41/Ser45) or non-phosphorylated
(Ser33/Ser37) β-catenin or β-actin. After washing with TBST, the membranes were
incubated with horseradish peroxidase-conjugated secondary anti-rabbit antibody (Bio-
Rad). The bound antibodies were visualized using ECL reagents (Amersham Biosciences).
2.5. Cell proliferation and migration assays
Cell proliferation was assayed by counting cell numbers. IMGE-5 cells were seeded
in a 96-well plate at a density of 2–5×103 cells/well in DMEM containing 5% FBS and
1 unit/ml γ-interferon, and cultured at 33 °C. On the following day, the cells were
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Ggly (10 nM) in 0.5% FBS in DMEM at 39 °C for another 24 h, and trypsinized off the
plates and viable cells were counted.
To measure cell migration, wound healing experiments were performed as detailed
previously [41]. Brieﬂy, IMGE-5 cells were grown in 12-well plates in DMEM at 33 °C
until they reached 80% conﬂuence, and then shifted to 39 °C and serum-starved for 24 h.
After the conﬂuent monolayer of cells had been wounded with a 20 μl-pipette tip, cells
were washed 3 times with PBS and treated with Gamide (10 nM) or Ggly (10 nM) in
DMEM containing 0.1% FBS. At this lower concentration of FBS, gastrin-induced cell
proliferationwas greatly decreased, so that wound closure would mainly correspond toFig. 2. Gastrins promote dissociation of β-catenin from E-cadherin and decrease expression
(10 nM) or Ggly (10 nM) for 4, 6, or 24 h. (A) At each time, cell lysates were immunoprecipita
or β-catenin antibodies as described in Materials and methods. PAK1K299A: a kinase-inactiv
blottingwith anti-E-cadherin or β-actin antibodies as described inMaterials andmethods. Th
for the non-stimulated un-transfected cells at time 0. The total amount of E-cadherinwas calc
summarise data from three independent experiments. ⁎: Pb0.05; KD: kinase-inactive mutamigration. Morphology and migration of cells were observed and photographed imme-
diately, and after 24 h. Wound width was measured at six different positions on the
photographs, and averages calculated.
2.6. In vitro and in vivo phosphorylation assay
The in vitro PAK1 kinase autophosphorylation assay was performed as described
previously [42]. Serum-starved cells were treated with Gamide (10 nM) or Ggly (10 nM)
for the periods of time indicated in the text. The cell lysates were incubated with anti-
PAK1 antibody and protein A beads for 4 h at 4 °C, and the immunoprecipitates subjectedof E-cadherin through a PAK1-dependent pathway. Cells were stimulated with Gamide
ted with an anti-β-catenin antibody, followed byWestern blotting with anti-E-cadherin
e mutant. (B) The Gamide-treated cell lysates were also directly subjected to Western
e amount of E-cadherin bound to β-cateninwas calculated relative to the value observed
ulated similarly. Similar results were observed for Ggly (data not shown). The bar graphs
nt of PAK1; IP: immunoprecipitation.
1948 H. He et al. / Biochimica et Biophysica Acta 1783 (2008) 1943–1954to PAK1 kinase autophosphorylation assay [42]. The radioactive phosphorylated bands
were visualized with a BAS-1800II phosphoimager (Berthold). Amounts of PAK1 protein
were determined by immunoblotting.
For the in vivo phosphorylation assay, cells were cultured to 50% conﬂuence at 33 °C
in DMEM without phosphates. After 24 h serum starvation at 39 °C, the cells were
treated with Gamide (10 nM) or Ggly (10 nM) in the presence of [32P] orthophosphate
for the time indicated in the text. Cell lysates were immunoprecipitated with anti-β-
catenin antibody and then separated by 10% SDS-polyacrylamide gels. The phosphory-
lated protein bands were visualized by autoradiography with a BAS-1800II phosphoi-Fig. 3. Effect of gastrins on β-catenin phosphorylation. Cells were incubated with Gamide (10
The cell lysates were blotted with anti-phos-Thr41/Ser45-β-catenin and anti-β-catenin an
immunoblotting. (C) Cells were stimulated with Gamide (10 nM) or Ggly (10 nM) for the in
Ser37)-β-catenin or anti-β-catenin antibodies as described in Materials and methods. The ba
inactive mutant of PAK1.mager (Berthold), and the total β-catenin contained in the immunoprecipitates was
detected by Coomassie blue staining.
2.7. Statistical analysis
All values are expressed as means±SE. Results were analyzed by one-way analysis
of variance. If there was a statistically signiﬁcant difference in the data set, individual
values were compared by Bonferroni's t test with the unstimulated control, or with thenM) or Ggly (10 nM) for either (A) short (5, 15 or 30 min) or (B) long (4, 6 or 24 h) times.
tibodies. Similar results were obtained in two other independent experiments. IB:
dicated times, and lysates were Western blotted with anti-non-phosphorylated (Ser33/
r graphs summarise data from three independent experiments. ⁎: Pb0.05; KD: kinase-
1949H. He et al. / Biochimica et Biophysica Acta 1783 (2008) 1943–1954values obtained in the presence of Ggly or Gamide, as appropriate. Differences with
Pb0.05 were considered signiﬁcant.
3. Results
3.1. PAK1 associates with β-catenin and mediates induction of its nuclear
translocation by gastrins
To determine the role of PAK1 in the regulation of β-catenin
signalling by gastrins, we ﬁrst investigated whether PAK1 associates
with β-catenin, and the effects of gastrins on this association. Cells
were stimulated with Gamide (10 nM) or Ggly (10 nM) for 15, 30 or
60 min. After stimulation, the cells were lysed, the cell lysates were
immunoprecipitated with anti-PAK1 antibody, and the immunopre-
cipitates were Western blotted with anti-β-catenin antibody as
described in Materials and methods. As shown in Fig. 1A, PAK1 was
associated with β-catenin in the absence of gastrins. Neither Gamide
nor Ggly signiﬁcantly changed the association between PAK1 and
β-catenin under the experimental conditions used. Similarly the total
β-catenin expression was not affected by either Gamide or Ggly.
To investigate the biological relevance of the association between
PAK1 and β-catenin, the cellular localization of PAK1 and β-catenin
was assessed by immunoﬂuorescent staining followed by confocal
microscopy. Cells were stimulated with either Gamide (10 nM) or Ggly
(10 nM) for 1 h or 24 h. After stimulation, the cells were subjected to
immunoﬂuorescent staining with anti-PAK1 or anti-β-catenin anti-
bodies as described inMaterials andmethods. In untreated cells, PAK1
mostly co-localized with β-catenin in the membrane area (Fig. 1B
and C). After 1 h stimulationwith Gamide or Ggly, PAK1 and β-catenin
had gathered around the nucleus (Fig. 1B). After 24 h stimulationwith
Gamide or Ggly, PAK1 co-localized with β-catenin in the nucleusFig. 4. Gastrins increase β-catenin associationwith TCF4 in a PAK1-dependent manner. Cells
lysates were immunoprecipitated with anti-TCF4 antibody, followed by Western blotting w
amount of β-catenin bound to TCF4 was calculated relative to the value observed for the no
independent experiments. ⁎: Pb0.05; KD: kinase-inactive mutant of PAK1; IP: immunoprec(Fig. 1C and F). To determine how PAK1 is involved in the gastrin-
induced nuclear co-localization of PAK1 and β-catenin, we transfected
cells with a kinase-inactive mutant PAK1K299A, which has been
successfully used to block wild type PAK1 function in previous reports
(reviewed by Bokoch, [43]). The gastrin-stimulated nuclear transloca-
tion of PAK1 and β-catenin was not observed in cells transfected with
kinase-inactive PAK1 (Fig. 1D and F). In contrast in these cells most
PAK1 and β-catenin still co-localized in the membrane area in the
presence of gastrins. Furthermore, when PAK1 protein expression
was reduced by transfecting cells with PAK1 small interfering RNA, the
β-catenin remained in association with the membrane even in the
presence of gastrins (Fig. 1E and F). These results indicate that both
Gamide and Ggly induced β-catenin translocation from the cell
membrane to the nucleus via a PAK1-dependent pathway.
3.2. The PAK1K299A mutant blocks the gastrin-stimulated dissociation of
β-catenin from E-cadherin
To investigate how PAK1mediates the gastrin-stimulated transloca-
tion of β-catenin from the cell membrane to the nucleus, both non-
transfected cells and cells transfected with the kinase-inactive mutant
PAK1K299Awere incubatedwithGamide (10 nM) or Ggly (10 nM) for 4, 6
or 24 h. At each time the cells were lysed, and the cell lysateswere used
to determine the association between β-catenin and E-cadherin, as
described inMaterials andmethods. BothGamide andGgly reduced the
amount of E-cadherin associated with β-catenin in a time-dependent
manner (Fig. 2A). After 24 h of incubation, both gastrins had
signiﬁcantly decreased the amount of E-cadherin bound to β-catenin
to 23% (Gamide) or 33% (Ggly) of the value at time zero (Fig. 2A). The
gastrin-induced dissociation of β-catenin from E-cadherin was com-
pletely blocked by the kinase-inactive mutant PAK1K299A. Furthermorewere stimulated with Gamide (10 nM) or Ggly (10 nM) for 4, 6, or 24 h. At each time, cell
ith anti-β-catenin or TCF4 antibody as described in the Materials and methods. The
n-stimulated un-transfected cells at time 0. The bar graphs summarise data from three
ipitation.
Fig. 5. Gastrins stimulate the expression of c-myc and cyclin D1 via a PAK1-dependent
pathway. Cells were stimulated with Gamide or Ggly for 2, 4, 8 or 24 h. At each time, cell
lysateswereWestern blottedwith anti-c-myc, anti-cyclin D1 or anti-β-actin antibodies as
described in Materials and methods. Both Gamide and Ggly stimulated c-myc (A) and
cyclin D1 (B) expression in a time-dependentmanner, and the stimulationwas blocked in
cells transfectedwith kinase-inactive PAK1K299A. The bar graphs inA andB summarise the
data obtained with the non-transfected cells in three independent experiments.
⁎: Pb0.05; ⁎⁎: Pb0.01; KD: kinase-inactive mutant of PAK1.
Fig. 6. Gastrins enhance cell proliferation and migration through a PAK1-dependent pathway. C
determined by cell counting as described in Materials and methods. Both Gamide and Ggly si
migration assay described inMaterials andmethods, bothGamide andGgly after 24 h of stimulat
innon-stimulated control cellswas 40%of the size at time zero (B,D). The signiﬁcant reduction in
inactive mutant PAK1K299A (C, D). The bar graph summarises the results from three independen
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manner, and the decrease was also blocked by the kinase-inactive
mutant PAK1K299A (Fig. 2B). Similar resultswere observed forGgly (data
not shown). These results indicate that both gastrins decreased the
expression of E-cadherin, and induced dissociation of β-catenin from
the remaining E-cadherin, via a PAK1-dependent pathway.
3.3. Effects of gastrins on phosphorylation and degradation of β-catenin
Cytoplasmic β-catenin forms a complex with CK-1, GSK-3, APC and
axin. Phosphorylation of β-catenin at Ser45 by CK-1 provides a
recognition site for GSK-3 and allows it to phosphorylate β-catenin
at positions Thr41, Ser37, and Ser33 [11–13]. The phosphorylated
β-catenin is then targeted for ubiquitination and degradation.
To determine whether or not gastrins have any effect on the
ubiquitination and degradation of β-catenin, cells were incubated
with Gamide or Ggly for either short (5, 15 or 30 min) or long (4, 6
and 24 h) times. The phosphorylated β-catenin was detected
with anti-phos-Thr41/Ser45-β-catenin antibody which recognizes
β-catenin phosphorylated at Ser45 or Thr41. Neither Gamide nor
Ggly affected the amount of phosphorylated β-catenin in either
short (Fig. 3A) or long (Fig. 3B) time frames. Since phosphorylation
of β-catenin at residues Ser45 or Thr41 normally targets β-catenin
for degradation, these results indicate that gastrins are unlikely to
have any signiﬁcant effect on the degradation of β-catenin.
β-catenin without phosphorylation at positions Ser45, Thr41, Ser37,
and Ser33 is stabilized in the cytoplasm. The stabilized, hypo-
phosphorylated β-catenin can then translocate into the nucleus
where it can bind transcriptional factors and regulate gene expression.
The effect of gastrins on phosphorylation of β-catenin at Ser37 and
Ser33 was assessed by Western blot using an anti-β-catenin antibody
that recognizes non-phosphorylated Ser33 and Ser37 residues. The
observation that both Gamide and Ggly increased the amount of non-
phosphorylated β-catenin in a time-dependent manner, without
changing total β-catenin expression (Fig. 3C, left panels of Western
blot and dark bars of graph), suggests that both gastrins stabilized
cytoplasmic β-catenin and promoted its activation. This activation of
β-catenin by gastrins was completely inhibited in cells transfected
with the kinase-inactive mutant PAK1K299A (Fig. 3C, right panels of
Western blot and grey bars of graph). These results indicate that
gastrins stabilized and activated β-catenin in a PAK1-dependent
manner by reduction of phosphorylation at the residues (in this case
Ser33 and Ser37) that are important for β-catenin degradation in the
ubiquitin system.
3.4. The PAK1K299A mutant blocks the gastrin-stimulated association of
β-catenin with TCF4
The above results indicate that gastrins activate β-catenin through
a PAK1-dependent pathway and induce a shift of β-catenin from the
cell membrane to the nucleus. Both Gamide and Ggly increased the
amount of β-catenin associated with the transcription factor TCF4 in a
time-dependent manner (Fig. 4). After 24 h of incubation, the amount
of β-catenin bound to TCF4 was signiﬁcantly increased by 80%
(Gamide) or 100% (Ggly) (Fig. 4). The gastrin-induced increment in
β-catenin bound to TCF4 was completely blocked in cells transfected
with the kinase-inactive mutant PAK1K299A. These results are
consistent with the observed induction by both gastrins of transloca-
tion of β-catenin from the cell membrane to the nucleus via a PAK1-
dependent pathway.ells were stimulated with Gamide (10 nM) or Ggly (10 nM) for 24 h. Cell proliferation was
gniﬁcantly increased cell number to 2 and 1.7 folds of control, respectively (A). In the cell
ion reduced thewound to 10% or 18%, respectively, of the size at time zero,while thewound
wound size induced bygastrinswas completely blocked in cells transfectedwith thekinase-
t experiments. ⁎: Pb0.05; ⁎⁎: Pb0.01; Cont: control; KD: kinase-inactive mutant of PAK1.
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c-myc and cyclin D1, and of cell proliferation and migration
Since activation of the β-catenin/TCF4 transcriptional complex in
other systems induces increased expression of genes, such as c-myc
and cyclin D1, which then trigger cell migration and proliferation
[9,10], the role of PAK1 in the regulation of β-catenin/TCF4 signalling
by gastrins was further investigated. Cells were incubated with
Gamide (10 nM) or Ggly (10 nM) for 2, 4, 8, or 24 h, and the
expression of c-myc and cyclin D1 was detected by Western blotting
as described in Materials and methods. Both Gamide and Ggly
increased the expression of c-myc (Fig. 5A) and cyclin D1 (Fig. 5B).
The enhancement by gastrins of the expression of c-myc and cyclin D1
was completely blocked in cells transfected with the kinase-inactive
mutant PAK1K299A. The basal expression of c-myc and cyclin D1 in
cells transfected with the kinase-inactive mutant PAK1K299A was
reduced. Cell proliferation and migration were then determined by
cell counting and wound healing assays, respectively, as described in
Materials and methods. After 24 h incubation, both Gamide and Ggly
signiﬁcantly stimulated cell proliferation by increasing the cell
number approximately 2- (Gamide) or 1.7-fold (Ggly) (Fig. 6A). The
stimulation of cell proliferation by either Gamide or Ggly was
completely inhibited in cells transfected with the kinase-inactive
mutant PAK1K299A. Likewise after 24 h incubation, both Gamide and
Ggly enhanced cell migration as indicated by a signiﬁcantly reduced
wound size compared to the non-stimulated control (Fig. 6B and D).
The enhancement of cell migration by either Gamide or Ggly was also
completely inhibited in cells transfected with the kinase-inactive
mutant PAK1K299A (Fig. 6C and D). These results indicate that PAK1 is
also required for the stimulation of the expression of c-myc and cyclin
D1, and cell proliferation and migration, by gastrins.Fig. 7. PAK1 is required for gastrin-stimulated phosphorylation of β-catenin. (A) Cell
lysates were immunoprecipitated with an anti-PAK1 antibody and in vitro phosphor-
ylation was assayed as described in Materials and methods. Both Gamide and
Ggly stimulated not only the autophosphorylation and activation of PAK1 but also
phosphorylation of a proteinwith an apparent molecular mass of 90 to 95 kDa. (B) Cells
were subjected to an in vivo phosphorylation assay as described in Materials and
methods. Both Gamide and Ggly stimulated the phosphorylation of β-catenin, but no
increase in phosphorylation was observed in cells transfected with the kinase-inactive
mutant of PAK1. The β-catenin bands were from Coomassie blue-stained gels.
C: control; A: Gamide; G: Ggly. Similar results were obtained from three independent
sets of experiments.3.6. PAK1 is required for the phosphorylation and activation of
β-catenin stimulated by gastrins
In addition to the sequential phosphorylation at its N-terminus by
CK1 andGSK-3β that targetsβ-catenin to the ubiquitin system [11–13],
phosphorylation of β-catenin at other sites enhances β-catenin
transcriptional activity by stabilizing the β-catenin protein [44–47].
The possibility that PAK1 might be involved in activation of β-catenin
by phosphorylation at other sites was therefore investigated. When
anti-PAK1 immunoprecipitates were subjected to an in vitro phos-
phorylation assay, another phosphorylated protein with a molecular
mass between 90 and 95 kDa (p90/95) was apparent as well as PAK1
(Fig. 7A). Phosphorylation of both PAK1 and p90/95 was stimulated by
gastrins. To determine whether p90/95 was β-catenin, as its size
suggested, an in vivo phosphorylation assay was performed. Both non-
transfected cells and cells transfected with the kinase-inactive mutant
PAK1K299A were stimulated with Gamide or Ggly in the presence of
[32P]-phosphate for 5 or 15 min, and β-catenin was immunoprecipi-
tated from cell lysates as described in Materials and methods. A
radioactive band of the size expected forβ-cateninwas observed in the
anti-β-catenin immunoprecipitates. Both Gamide and Ggly stimulated
the phosphorylation of β-catenin in vivo (Fig. 7B), and stimulationwas
blocked in cells transfectedwith the kinase-inactivemutant PAK1K299A
(Fig. 7B). These results indicate that gastrins may activate β-catenin, in
a PAK1-dependent manner, by stimulating phosphorylation at those
residues which promote nuclear translocation.
4. Discussion
Although the intracellular signalling pathways activated bygastrins
have been subjected to intense scrutiny, until now there has been little
evidence to connect gastrins with the Wnt pathway. We reported
previously that Ggly stimulated PI3-kinase-dependent phosphoryla-
tion of β-catenin on tyrosine with consequent disruption of adherens
junctions [29], and that progastrin induced the dissociation of both
adherens and tight junctions [48]. The gastrin gene has also been
identiﬁed as a target of β-catenin/TCF signalling in a mouse model of
APC [32]. We now report that both Gamide and Ggly induce phos-
phorylation and activation of β-catenin in a PAK1-dependent manner,
dissociation of β-catenin from E-cadherin, translocation of β-catenin
from the cell membrane to the nucleus, and association of β-catenin
with the transcriptional factor TCF4. This association further stimu-
lates expression of the c-myc and cyclin D1 genes leading to cell
migration and proliferation (Fig. 8).
PAK1 mediates gastrin-induced β-catenin translocation from the
cell membrane to the nucleus by promoting the dissociation of
β-catenin from E-cadherin. Furthermore PAK1 initiates the gastrin-
induced dissociation of β-catenin from E-cadherin at least partly by
inhibition of E-cadherin expression as PAK1 has previously been shown
to phosphorylate the transcription factor Snail, which then translocates
into the nucleus and represses E-cadherin gene transcription [35].
The dissociation ofβ-catenin fromE-cadherinwill increase cytoplasmic
β-catenin which will bind to the APC/axin complex where β-catenin is
to be phosphorylated sequentially at residues Ser45, Thr41, Ser37 and
Ser33 and hence targeted for ubiquitination and degradation [11–13].
Alternatively, the β-catenin with less phosphorylation of these
neighbouring residues will translocate to the nucleus where it will
bindwith transcriptional factors such as TCF4 andmodulate expression
of genes such as c-myc and cyclin D1 [9,10]. Although neither Gamide
nor Ggly changed the phosphorylation of β-catenin at residues Ser45
and Thr41, both Gamide and Ggly signiﬁcantly decreased the phosphor-
ylation ofβ-catenin at residues Ser37 and Ser33, leading to an increase in
hypo-phosphorylatedβ-cateninwhichwill translocate into the nucleus
and mediate nuclear signalling through the Wnt pathway. Indeed
gastrins signiﬁcantly increased the association of β-catenin with TCF4,
and the expression of c-myc and cyclin D1 (Figs. 4 and 5).
Fig. 8. Involvement of PAK1 in the regulation of β-catenin signalling by gastrins. Gastrins activate PAK1 via both Rac/Cdc42-dependent and independent pathway(s) [39], leading to
decreased phosphorylation of β-catenin at residues Ser37 and Ser33 and increased phosphorylation of β-catenin at other undeﬁned sites. Both phosphorylation changes probably
contribute to β-catenin stabilization and activation in the cytoplasm. Furthermore active PAK1 inhibits E-cadherin expression and causes E-cadherin to dissociate from β-catenin,
allowing β-catenin to translocate from the cell membrane via the cytoplasm to the nucleus. In the nucleus, β-catenin associates with TCF4 and promotes the expression of genes, such
as c-myc and cyclin D1, which trigger and enhance cell proliferation and migration.
1953H. He et al. / Biochimica et Biophysica Acta 1783 (2008) 1943–1954C-myc and cyclinD1 arewell recognized as target genes ofβ-catenin/
TCF4 signalling. However the possibility cannot be excluded that
gastrins may also regulate the expression of c-myc and cyclin D1
through a PAK1-dependent, but β-catenin/TCF4-independent, pathway
as our data have shown that both Gamide and Ggly increase the
expression of c-myc and cyclinD1 after as little as 2 h stimulation (Fig. 5)
while stimulation for 6 h is required before signiﬁcant association of
β-catenin with TCF4 (Fig. 4), and hence activation of β-catenin/TCF4
signalling, is observed. Furthermore, the expression of c-myc and cyclin-
D1 is reduced in cells transfected with the kinase-inactive mutant
PAK1K299A regardless of whether or not the cells are stimulated by
gastrins (Fig. 4). These results suggest that PAK1 mediates gastrin-
stimulated gene expression of c-myc and cyclin D1 through diverse
signalling cascades, one of which is the β-catenin/TCF4 signalling
pathway.
In addition to sequential phosphorylation at its N-terminus by CK-1
and GSK-3β [11–13], β-catenin can be phosphorylated by CK-2 at
Thr393 [44], and by PKA at Ser675 [45,46]. The latter two phosphoryla-
tions enhance β-catenin transcriptional activity by stabilizing the β-
catenin protein. Recently it has been reported that AKT phosphorylates
β-catenin at Ser552 and promotes β-catenin transcriptional activity
[47]. In our experiments gastrins not only induced, in a PAK1-
dependent manner, decreased phosphorylation of β-catenin at Ser37
and Ser33 by GSK-3β, but also stimulated the phosphorylation of β-
catenin at other as yet unidentiﬁed sites, which could contribute to the
enhancement ofβ-catenin transcriptional activity bygastrins. Our data
have demonstrated that PAK1 is required not only for the gastrin-
induced activation ofβ-catenin, but also for activation of theβ-catenin/
TCF4 transcriptional pathway by gastrins. Since gastrins activate PI3K/
AKT signalling through multiple pathways [28–31] and PAK1 can be
phosphorylated and activated by PI3K/AKT [37], it is possible that PAK1functions as a downstream point of convergence of multiple signals
generated by gastrins in the regulation of β-catenin. Indeed we have
found that in two human colon cancer cell lines (HT29 and HCT116),
PAK1 associated with β-catenin and gastrins activated PAK1 kinase
activity via a PI3K-dependent pathway (unpublished data).
In conclusion, thepresentpaper provides theﬁrst evidence that PAK1
is essential for the regulation of the β-catenin pathway by gastrins. This
observation places PAK1 in an important position in the intracellular
Wnt/β-catenin pathway. Since Wnt/β-catenin signalling plays a crucial
part in the development of gastric and colorectal carcinomas [21–23],
the discovery of a role for PAK1 inWnt/β-catenin signallingwill provide
new insights for treatment of gastrointestinal malignancies.
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